First-in-class hafnium oxide nanoparticles NBTXR3 in the treatment of liver cancers.

Enrique Chajon,Marc Pracht,Yan Rolland,Thierry de Baere,Jean-Pierre Bronowicki,Véronique Vendrely,Antonio Sa Cunha,A.-S. Baumann,Laurent Valérie,Emmanuel Rio,Samuel Le Sourd,P. Gustin,C. Perret,Didier Peiffert,Eric Deutsch

First-in-class hafnium oxide nanoparticles NBTXR3 in the treatment of liver cancers.

2019

Enrique Chajon
Marc Pracht
Yan Rolland
Thierry de Baere
Jean-Pierre Bronowicki
Véronique Vendrely
Antonio Sa Cunha
A.-S. Baumann
Laurent Valérie
Emmanuel Rio
Samuel Le Sourd
P. Gustin
C. Perret
Didier Peiffert
Eric Deutsch

e15642Background: Hafnium oxide nanoparticles, NBTXR3, increase the effect of radiotherapy (RT) by enhancing local energy dose deposit within tumor cells, resulting in increased cell death compared...

Keywords:

Nanoparticle
Pathology
Hafnium oxide
Cancer research
Medicine
Radiation therapy
tumor cells
Programmed cell death
energy dose

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations